Clinical and Laboratory Features of PCR-Confirmed and Clinically Suspected COVID-19 Pediatric Patients: A Single Hospital-Based Experience During the First COVID-19 Wave in the United Arab Emirates.
COVID-19
SARS-CoV-2
United Arab Emirates
children
pediatrics
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
12
2021
accepted:
04
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
This study investigated clinical and laboratory differences between confirmed (RT-PCR-positive) and clinically suspected (RT-PCR-negative) COVID-19 pediatric patients, and explored factors associated with disease severity at presentation and duration of hospitalization. Medical charts of COVID-19-confirmed and clinically suspected pediatric patients admitted to a tertiary hospital in Abu Dhabi were reviewed. Sociodemographic information and clinical and laboratory outcomes were retrieved and analyzed. Between 1 April to 30 June, 2020, 173 patients (mean age: 3.6 ± SD 3.2 years) presented with respiratory symptoms. Of them, 18.0% had confirmed contact with COVID-19 cases, 66.5% had symptoms for ≤3 days, and 86.7% were with moderate to severe disease. Twenty-eight (16.1%) patients tested positive while the rest (83.8%) tested negative in RT-PCR. COVID-19-confirmed and clinically suspected patients were statistically similar ( In pediatric patients with negative RT-PCR, COVID-19 is still suspected based on clinical symptoms and epidemiological data. A tentative diagnosis can be made based on a thorough examination, and proper medical management can be initiated promptly.
Identifiants
pubmed: 35372173
doi: 10.3389/fped.2022.830587
pmc: PMC8965316
doi:
Types de publication
Journal Article
Langues
eng
Pagination
830587Informations de copyright
Copyright © 2022 Eldin, Saleh, Labib, Othman, Chacko, Mae, Elnour and Al-Rifai.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Pediatr. 2020 Jul;179(7):1029-1046
pubmed: 32424745
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1249-1254
pubmed: 34499628
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Curr Med Sci. 2020 Apr;40(2):275-280
pubmed: 32207032
Front Pediatr. 2020 Jul 03;8:431
pubmed: 32719759
Innovation (N Y). 2020 Nov 25;1(3):100061
pubmed: 33169119
Front Pediatr. 2021 Jan 18;8:603741
pubmed: 33537264
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Lancet Infect Dis. 2020 Jun;20(6):689-696
pubmed: 32220650
Saudi Med J. 2021 Apr;42(4):391-398
pubmed: 33795494
J Korean Med Sci. 2020 Jun 29;35(25):e236
pubmed: 32597047
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Pediatr Pulmonol. 2020 Oct;55(10):2565-2575
pubmed: 32725955
J Pediatr. 2021 Mar;230:23-31.e10
pubmed: 33197493
JAMA Pediatr. 2020 Sep 1;174(9):868-873
pubmed: 32392288
Dtsch Arztebl Int. 2020 May 22;117(21):373-374
pubmed: 32519943
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Infect Dis. 2020 Sep 12;71(6):1547-1551
pubmed: 32112072
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
PLoS One. 2021 Feb 12;16(2):e0246903
pubmed: 33577582
World J Pediatr. 2020 Jun;16(3):240-246
pubmed: 32026148
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
BMC Med. 2020 May 6;18(1):123
pubmed: 32370747
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
Infection. 2021 Oct;49(5):889-905
pubmed: 34170486
Indian Pediatr. 2020 Sep 15;57(9):820-826
pubmed: 32583808